InvestorWire NewsRoom

Article

Green Hygienics Holdings Inc. (GRYN) Offers Ideal Source for Long-term Clinical Research Studies
March 25, 2021

Green Hygienics Holdings Inc. (GRYN) Offers Ideal Source for Long-term Clinical Research Studies

  • Company owns largest single USDA-certified, organic hemp for CBD farm in North America with 824 acres, 400,000 square feet of greenhouse space
  • GRYN registered with U.S. Food and Drug Administration in August last year
  • Company has capacity to deliver large volume supply chain of premium quality product while remaining compliant for research or regulatory approvals

With a goal of being the leader in both compliance and capabilities in the hemp and cannabinoid supply market, California-based, innovative, technology-driven company Green Hygienics (OTCQB: GRYN) is committed to offering the highest-quality and safest products available. GRYN owns and operates the largest single USDA-certified, organic-hemp farm in North America. The farm property has 824 acres of outdoor cultivation potential and 400,000 square feet of greenhouse space, which supports the Company in this capacity.

In order to participate in long-term clinical research studies, companies must source their materials from the same company over the entire period of the study. This is critically important as it adds credibility and validity to the study results because it maintains consistency and eliminates variables.

When entering into a cooperative research study, it is essential that the Institutional Review Board (“IRB”) take into account the facilities and capabilities of the source (https://ibn.fm/YQq1X). Throughout the entire study, suppliers are expected to show that they can consistently manufacture a quality product and submit sufficient information to ensure the identity, quality, purity, and potency or strength of the investigational drug.

A supply needs to be obtained from a business that has adequate facilities and capabilities, with every variable accounted for and controlled from beginning to end. The supplier must remain in compliance throughout the study while also being capable of meeting demand.

In April of last year, GRYN received its USDA Organic Certification (https://ibn.fm/W5oEp). In August, GRYN registered with the U.S. Food and Drug Administration (https://ibn.fm/hkQQP). These strategic moves strengthened the Company’s ability to provide product efficacy to both the pharmaceutical and consumer industries. With foundational accreditations in place, and additional industry first certifications on the horizon, the Company offers research solutions that few others in the industry are capable of. Additionally, Green Hygienics offers a secure, single-origin supply chain of significant size with 400,000 square feet of indoor greenhouse space providing for year-round cultivation.

As other hemp farmers took a step back in 2020, licensed acres dropped by 27% (https://ibn.fm/anqyj). GRYN, however, will increase its cultivation capacity in 2021 and stay committed to its mission to become the critical supply chain solution from seed to product.

The Company’s commitment and ability to provide both volume and consistency of hemp-derived cannabinoids makes it an ideal supplier for long-term studies within the medical, nutraceutical and pharmaceutical industries.

For more information about this company, visit www.GreenHygienics.com.

NOTE TO INVESTORS: The latest news and updates relating to GRYN are available in the company’s newsroom at http://ibn.fm/GRYN

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(310) 299-1717

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up InvestorNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).